3588 results about "Phenylene" patented technology

A liquid crystal display device produced through the steps of injecting a polymerizable monomer-containing liquid crystal composition between two substrates and, while applying a voltage between opposing transparent electrodes of the substrates, polymerizing the monomer, wherein the polymerizable monomer contained in the liquid crystal composition has one or more ring or condensed ring structures and functional groups bonded directly to the ring or condensed ring structure.The monomer is preferably represented by the following general formula:P1-A1-(Z1-A2)n-P2wherein P1 and P2 are acrylates or the like, A1 and A2 are 1,4-phenylenes or the like, Z1 is —COO— or the like, and n is 0 to 2.

A compound represented by the following general formula (1a) or (1b), a liquid crystal composition containing the compound, and a polymer obtained by polymerizing the compound or the composition: wherein R1 represents a fluorine atom, an alkyl group or the like; Y1 and Y2 each independently represents alkylene or the like; A1, A2, B1 and B2 each independently represents 1,4-cyclohexylene, 1,4-phenylene or the like; X1 and X2 each independently represents a single bond, —COO—, —OCO— or the like; m represents 0, 1 or 2; and G represents hydrogen, methyl or the like.

A composition comprising a polymerizable compound of the formula (1) and a rod-shaped polymerizable liquid crystal compound: P2-E2-X2-B2-A2-(G2)t-Y-(G1)s-A1-B1-X1-E1-P1   (1) (in the formula (1), Y represents a di-valent group, s and t represent each independently an integer of 0 or 1, G1 and G2 when s and t are 1 represent each independently —CR1R2—, R1 and R2 represent each independently an alkyl group having 1 to 4 carbon atoms, halogen atom or hydrogen atom, A1 and A2 represent each independently a di-valent cyclic hydrocarbon group, di-valent heterocyclic group, methylenephenylene group, oxyphenylene group or thiophenylene group, B1 and B2 represent each independently a di-valent group, X1 and X2 represent each independently a di-valent group, E1 and E2 represent each independently an alkylene group having 2 to 25 carbon atoms, and P1 and P2 represent a hydrogen atom or polymerizable group, at least one of P1 and P2 being a polymerizable group.).

The invention belongs to the technical field of preparation of a carbon nano material, and particularly relates to a method for preparing a carbon dot having a high fluorescent quantum yield from citric acid and different nitrogen-containing molecules. The method comprises the following steps: weighing 1-10 mmol of solid citric acid, and dissolving in 10 ml of deionized water; weighing 1-10 mmol of ethylenediamine, ethylamine, propylamine, butanediamine, n-hexylamine, p-phenylene diamine or urea, adding into the citric acid solution, and uniformly stirring; transferring the solution into a hydrothermal or high-pressure microwave reaction kettle, reacting under hydrothermal or microwave conditions, and naturally cooling the reaction kettle to room temperature, thus obtaining a yellow or brown carbon dot water solution; and finally, purifying the carbon dot water solution, evaporating, and drying to obtain pure carbon dot solid powder. The carbon dot solution can send out bright blue fluorescence under the irradiation of a handheld ultraviolet lamp. The invention has wide application prospects in the fields of biological imaging, fluorescent printing and the like.

Provided are an aromatic amine compound represented by the following Formula (1) and an organic electroluminescent element which has at least one organic thin film layer containing the above aromatic amine derivative in the form of a single component. The organic electroluminescent element described above has a high luminescent efficiency even at a low voltage and a long life. It can emit blue light even at high temperatures. In Formula (1), Ar1 and Ar2 each represent naphthyl and the like; Ar3 to Ar6 each represent phenyl, naphthyl, phenanthryl and the like; Ar7 to Ar10 each represent 1,4-phenylene and the like; L represents a single bond and the like; provided that the conditions of (1) and / or (2) are satisfied: (1) at least one of Ar3 to Ar6 is a condensed aryl group having 10 to 50 nuclear carbon atoms and (2) at least one of Ar1 and Ar2 is a condensed aryl group having 12 to 50 nuclear carbon atoms.

A compound represented by Formula 1 below:(R1)a—CB—[Ar]n—CB—(R2)b  <Formula 1>wherein CB denotes carborane, Ar is a substituted or unsubstituted phenylene group, and a detailed description of R1, R2, a, b, and n is provided in the detailed description. An organic light-emitting diode including an organic layer including the compound has high luminous efficiency.

The present invention generally relates to organic polymers able to participate in an analyte-recognition process, where an analyte facilitates an energy transfer between an energy donor and an energy acceptor. Certain embodiments of the invention make use of fluorescent conjugated polymers, such as poly(phenylene ethynylene)s and other polymers comprising pi-conjugated backbones. For example, one aspect of the invention provides a fluorescent conjugated polymer and an indicator that can interact with each other in the presence of an analyte to produce an emissive signal. In some cases, the interaction may include energy exchange mechanisms, such as Dexter energy transfer or the strong coupling effect. The interaction of the conjugated polymer and the indicator, in some instances, may be facilitated through specific interactions, such as a protein / carbohydrate interaction, a ligand / receptor interaction, etc. Another aspect of the invention provides for the detection of biological entities, for example, pathogenic bacteria such as E. coli, or viruses such as influenza virus. In some cases, biological recognition elements may be used to determine the biological entity, for instance, carbohydrates that can be used to specifically interact with at least part of the biological entity, such as a protein in the cell membrane of a bacterium. Still other aspects of the invention involve articles, devices, and kits using any of the above-described systems.

The present invention relates to a compound represented by Formula (1) and a polymer obtained using the compound: wherein R1 is phenyl which may have substituents, Q1 is hydrogen, halogen, alkyl having 1 to 10 carbon atoms, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl or phenyl in which optional hydrogen may be replaced by halogen or alkyl having 1 to 5 carbon atoms, and Q2 is a group represented by Formula (2) wherein the code < represents a bonding point with silicon, l, m, n and p are independently 0, 1, 2 or 3, A1 to A4 are independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, a condensed ring group having 6 to 10 carbon atoms which is a divalent group, or 1,4-phenylene, Z0 to Z3 are independently a single bond, —CH═CR—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms, and Z4 is a single bond, —CH═CH—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms. And Y1 in Formula (1) is the group defined in Claim 1.

A liquid crystal display device produced through the steps of injecting a polymerizable monomer-containing liquid crystal composition between two substrates and, while applying a voltage between opposing transparent electrodes of the substrates, polymerizing the monomer, wherein the polymerizable monomer contained in the liquid crystal composition has one or more ring or condensed ring structures and functional groups bonded directly to the ring or condensed ring structure. The monomer is preferably represented by the following general formula: P1-A1-(Z1-A2)n-P2 wherein P1 and P2 are acrylates or the like, A1 and A2 are 1,4-phenylenes or the like, Z1 is —COO— or the like, and n is 0 to 2.

The present invention includes the preparation of highly conducting conjugated polymers and their use as electrochemical actuators, A typical electrochemical actuator comprises a highly conducting, conjugated polymer for the anode or the cathode, or for both the anode and the cathode; suitable conjugate polymers have a conductivity ≧100 S / cm. The material may have any form, including films and fibers. A preferred shape is a strip or a fiber, where the fiber can be solid or hollow, although any shape may be used. Before use, the material may be treated, for example, by immersion in an acid, in order to dope / protonate the material or to introduce anions or to exchange the anion in the polymer for another anion. Other materials may be incorporated in the polyaniline to increase its conductivity or to provide other benefits, such as increased strength. Useful conducting polymers include monomers of anilines, pyrroles, thiophenes, phenylene vinylenes, and derivatives thereof.

Provided is a novel aromatic amine derivative represented by General Formula (G1) below. (In the formula, A represents oxygen or sulfur, and R1 to R7 individually represent any of a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted phenyl group, and a substituted or unsubstituted biphenyl group. In addition, α1 and α2 individually represent a substituted or unsubstituted phenylene group. Further, Ar1 represents a substituted or unsubstituted condensed aromatic hydrocarbon having 14 to 18 carbon atoms included in a ring. Further, Ar2 represents a substituted or unsubstituted aryl group having 6 to 13 carbon atoms included in a ring. Further, j and n are individually 0 or 1, and p is 1 or 2.)

The invention provides a liquid crystal compound that has an excellent compatibility with other liquid crystal compounds and also has at least one of characteristics such as a high stability to heat, light or the like, a suitable refractive index anisotropy (Δn), a low threshold voltage and a suitable dielectric anisotropy (Δ∈). A compound represented by formula (1).For example, R1 is alkyl having 1 to 10 carbons, R2 is halogen or alkenyl having 2 to 10 carbons; the ring A1, the ring A2 and the ring A3 are 1,4-cyclohexylene or 1,4-phenylene; Z1, Z2 and Z3 are a single bond or alkylene having 1 to 4 carbons; G is —CH2— or —O—; and m is 1, and n and p is 0 or 1.

An active matrix display comprises a chiral smectic liquid crystal mixture which has the phase sequence I-N*-SmC*, a spontaneous polarization in the operating temperature range of <40 nC / cm2 and a pitch of >10 mum at at least one temperature in the nematic or cholesteric phase and comprises at least one compound each from at least two of the substance classes (A), (B) and (C) and one or more compounds from substance class (D):(A): compounds comprising two rings which are directly linked to one another and are selected from phenylene-1,4-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl and pyridazine-2,5-diyl with the proviso that at least one of these rings is a nitrogen heterocycle;(B): compounds comprising three rings selected from phenylene-1,4-diyl, two of the rings being directly linked to one another and the third ring being linked to one of the other two rings via an -OC(=O)- or -C(=O)-group, with the proviso that at least one of the three rings is fluorophenylene-1,4-diyl or ortho-difluorophenylene-1,4-diyl;(C): compounds comprising three rings which are directly linked to one another and are selected from phenylene-1,4-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl and pyridazine-2,5-diyl with the proviso that at least one of these rings is a nitrogen heterocycle;(D): compounds comprising mesogenic groups suitable as components of liquid crystal mixtures.

An organic EL device comprising a cathode, an anode, and at least one organic compound layer containing an organic compound represented by formula (I):where L0 is any one of o-, p-, and m-phenylene groups which have two, three or four rings and which have a substituent with the proviso that when L0 is a phenylene group having four rings, the phenylene group may have an unsubstituted or substituted aminophenyl group somewhere therein, and at least one of R01, R02, R03 and R04 is any one of the following groups:where R1, R12, R13, R14, R15, R16 and R17 are each a substituted or unsubstituted aryl group, and r1, r2, r3 and r4 are each an integer of 0 to 5 with the proviso that r1+r2+r3+r4>=1.

The composite material comprise acid functionalized inorganic supports such as silica dispersed in a functionalized and / or non-functionalized polymer matrix that is based on numerous polymers such as poly(aromatic ether ketones), or poly(benzoyl phenylene), or derivatives thereof. The composite material is characterized by good water retention capabilities due to the acidic functions and the hydrophilicity of the silica particles. Moreover, a good impermeability to gas and liquid fuels commonly used in fuel cell technology, like hydrogen gas or methanol solution, is also obtained due to the presence of silica particles. Good mechanical properties of the composite material let the material to be formed easily in thin film or membrane form. In that form, the composite material is usable for proton exchange membrane for fuel cells, for drying or humidifying membrane for gas or solvent conditioning, or as acid catalytic membrane.

The present invention provides a class of 2,4-disubstituted phenylene-1,5-diamine derivatives, having an inhibiting effect on EGFR tyrosine kinases, and pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug of said derivatives. See the description for the definitions of each group in the formula. In addition, the present invention also discloses pharmaceutical compositions, pharmaceutically acceptable compositions, and applications thereof.

A compound represented by the following general formula (1). R3—(X)x-(A)a-(Y)y-(B)b-(Z)z-R12  (1) (A, B, X, Y, and Z represent the following general formulae, and CH on a phenylene ring of each of X, Y, and Z may be replaced with an N atom. a, b, x, y, and z each independently represent an integer of 0 to 5, and a≧1, y≧1, and a+b≧2. (R1 to R14 each independently represent a hydrogen atom, or a linear or branched alkyl group.)). The compound can be suitably used as a compound for an organic EL device.

New, economical and convenient procedures for the preparation of catecholborane in high chemically pure form using tri-O-phenylene bis borate readily prepared from the reaction of catechol with boric acid, and diborane or borane-Lewis base complexes.

Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—.R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R5-R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2-C6 substituted or unsubstituted alkylene group.Z is ═O or ═S.Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with taxol or an analog of taxol.

A process for producing a graphitic film comprising the steps of (a) mixing graphene platelets with a carbon precursor polymer and a liquid to form a slurry and forming the slurry into a wet film under the influence of an orientation-inducing stress field to align the graphene platelets on a solid substrate; (b) removing the liquid to form a precursor polymer composite film wherein the graphene platelets occupy a weight fraction of 1% to 99%; (c) carbonizing the precursor polymer composite film at a carbonization temperature of at least 300° C. to obtain a carbonized composite film; and (d) thermally treating the carbonized composite film at a final graphitization temperature higher than 1,500° C. to obtain the graphitic film. Preferably, the carbon precursor polymer is selected from the group consisting of polyimide, polyamide, polyoxadiazole, polybenzoxazole, polybenzobisoxazole, polythiazole, polybenzothiazole, polybenzobisthiazole, poly(p-phenylene vinylene), polybenzimidazole, polybenzobisimidazole, and combinations thereof.

Conjugates of transferrin, albumin and polyethylence glycol consisting of native or thiolated transferrin or albumin or of polyethylene glycol (MW between approximately 5,000 and 20,0000) with at least one HS-, HO- or H2N group and cytostatic compounds derived through maleinimide or N-hydroxysuccinimide ester compounds, such as doxorubicin, daunorubicin, epirubicin, idarubicin, mitoxandrone, chloroambucil, melphalan, 5-fluorouracyl, 5'-desoxy-5-fluorouridine, thioguanine, methotrexate, paclitaxel, docetaxel, topotecan, 9-aminocamptothecin, etoposide, teniposide, mitopodoside, vinblastine, vincristine, vindesine, vinorelbine or a compound of general formula A, B, C or D, where n=0-6, X=-NH2, -OH, -COOH, -O-CO-R-COR*, -NH-CO-R-COR*, where R is an aliphatic carbon chain with 1-6 carbon atoms or a substituted or unsubstituted phenylene group and R* H, phenyl, alkyl with 1-6 carbon atoms.

Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—.R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R5–R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2–C6 substituted or unsubstituted alkylene group.Z is ═0 or ═S.Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent.Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with taxol or an analog of taxol.

A cross-linked, supported polybenzimidazole membrane for gas separation is prepared by layering a solution of polybenzimidazole (PBI) and α,α′dibromo-p-xylene onto a porous support and evaporating solvent. A supported membrane of cross-linked poly-2,2′-(m-phenylene)-5,5′-bibenzimidazole unexpectedly exhibits an enhanced gas permeability compared to the non-cross linked analog at temperatures over 265° C.

A three-dimensional object is manufactured by selective sintering by means of electromagnetic radiation, wherein the powder comprises a polymer or copolymer having at least one of the following structural characteristics:(i) at least one branching group in the backbone chain of the polymer or copolymer, provided that in case of the use of polyaryletherketones (PAEK) the branching group is an aromatic structural unit in the backbone chain of the polymer or copolymer;(ii) modification of at least one end group of the backbone chain of the polymer or copolymer;(iii) at least one bulky group within the backbone chain of the polymer of copolymer, provided that in case of the use of polyaryletherketones (PAEK) the bulky group is not selected from the group consisting of phenylene, biphenylene, naphthalene and CH2— or isopropylidene-linked aromatics;(iv) at least one aromatic group non-linearly linking the backbone chain.

Compositions are disclosed which comprise mixtures of at least one compound selected from silicone elastomers, bis-, tri- or higher polymaleimides and / or bis-, tri- or higher polycitraconimides, and at least one compound selected from p-phenylene-diamine based antiozonants, sulfur compounds capable of accelerating sulfur vulcanization of polymers capable of being crosslinked by sulfur and polysulfide polymers which when compounded into polymers curable by free radical initiators in the presence of free radical initiators permit substantially tack free surface cure of the polymers by decomposition of the free radical initiator in the presence of molecular oxygen. Compositions containing the above ingredients and at least one free radical initiator, curable compositions containing the combination and processes for making and using the compositions are also disclosed.

Provided is a liquid-crystalline, polymerizable vinyl ketone compound of formula (1): Preferably, R1 is hydrogen, halogen, —CN, —CF3, —CF2H, —CFH2, —OCF3, —OCF2H, or alkyl, alkoxy, alkoxyalkyl or alkenyl having from 1 to 10 carbon atoms; R2, R3 and R5 are hydrogen; A1 to A4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene or 1,4-phenylene where any hydrogen may be substituted with halogen; Z1 to Z3 are independently a single bond, —(CH2)2—, —CH═CH—, —CF═CF—, —OCF2— or —CF2O—; Z4 is a single bond, —(CH2)3— or —(CH2)4—; m, n and q are independently 0, 1 or 2. The uppermost temperature of the liquid crystalline phase of the compound is high, and the compound has good compatibility with other compounds and has the necessary characteristics such as optical anisotropy. Also provided are a polymer having many good characteristics of transparency, mechanical strength, coatability, solubility, crystallinity, shrinkage, water permeability, water absorption, melting point, glass transition point, clearing point and chemical resistance; an optically-anisotropic material of the polymer; a liquid-crystal display device that comprises the polymer; and a method for producing the liquid-crystalline compound.

A liquid crystal composition having a negative dielectric anisotropy that includes three components, wherein the first component is a specific four-ring compound having phenylene, one hydrogen of which is replaced by fluorine, the second component is a specific compound having phenylene, two hydrogens of which are replaced by fluorine or chlorine, and the third component is a specific compound having two cyclohexylene rings, and a liquid crystal display device including the composition.

The present invention provides a compound which is useful as a PGI2 receptor agonist, and a pharmaceutical composition.The present invention is directed to a pharmaceutical composition comprising a compound represented by the following formula [1]:(R1 and R2 are the same or different and each represents optionally substituted aryl, Y represents N or CH, Z represents N or CH, A represents NH, NR5, O, S, or ethylene, R5 represents alkyl, D represents alkylene or alkenylene, E represents phenylene or single bond, G represents O, S, or CH2, R3 and R4 are the same or different and each represents hydrogen or alkyl, Q represents carboxy, alkoxycarbonyl, tetrazolyl, carbamoyl, or N-(alkylsulfonyl)carbamoyl), or a pharmaceutically acceptable salt thereof as an active ingredient.